Guggenheim reiterates Bristol-Myers Squibb stock rating at Buy
Entity Intersection Graph
No entity connections available yet for this article.
More from USA
- What execs, scouts are saying about the NFL draft class' most polarizing players
- Comedian Gianmarco Soresi Inks Deal for ‘The Downside’ Podcast With Vox Media
- House Democrat slams 'TACO' jokes about Trump's ceasefire with Iran
- Expert says Trump's Iran threats would be war crimes if they were carried out
- Eye Opener: U.S. and Iran reach 2-week ceasefire deal
- CEO shares a 'very dangerous' red flag in a boss—it makes employees feel like they 'signed up for a false promise'
News from Other Countries
🇬🇧 United Kingdom
- What we know about the two-week ceasefire between the US and Iran
- Dozens of WW2 phosphorus devices found at beach
- ‘We can’t increase prices any more’: UK hospitality firms hit by cost triple blow